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1    Introduction 
Cervical cancer is the second most common cancer in women worldwide and is a leading cause of can-
cer-related death in women in underdeveloped countries. Worldwide, approximately 500,000 cases of 
cervical cancer are diagnosed each year: approximately 13,000 cases of invasive cervical cancer and in 
the USA 50,000 cases of cervical carcinoma in situ (i.e., localized cancer) are diagnosed yearly. In devel-
oped countries, over the last 40 years, cervical cancer death rate has decreased by more than 70% because 
pre-invasive lesions and cervical cancers were detected at an earlier stage (Tinelli et al., 2009b). 
Cervical cancer is always associated with a HPV infection, since a carcinogenic human papillo-
mavirus (HPV) infection is necessary for the development of cervical cancer (Tinelli et al., 2007). Cervi-
cal cancer risk seems to be influenced by other variables too, like smoking and immunodeficiency. Infec-
tion with other sexually transmitted viruses seems to act as a cofactor in the development of cervical can-
cer (Tinelli et al., 2009a). 
We will focus on fertility-sparing techniques such as radical trachelectomy and on the area of 
minimally invasive treatment of cervical cancer, since this tumor can be safely and feasibly managed 
from minimally invasive endoscopic radical operations, such as hysterectomy, bilateral salpingo-
oophorectomy, pelvic and para-aortic lymphadenectomy for surgical treatment. 
2    Cervical Cancer Staging and Radical Hysterectomy Classification 
Correct staging of advanced cervical cancer is essential to optimize its oncological treatment. However, 
the new FIGO classification is limited to clinical findings and does not include complex imaging. The ra-
tionale is to provide a template allowing both resource-rich and resource-poor countries to compare data 
by stage so as to standardize management of the disease. It can be difficult to accurately assess parametri-
al and sidewall invasion, as well as metastases to lymph nodes, using clinical staging alone. These are the 
limitations of FIGO clinical staging. 
The purpose of the staging system is to provide uniform terminology for better communication 
among health professionals and to provide appropriate prognosis for the patients resulting in treatment 
improvement (Pecorelli et al., 2009). This is a constantly evolving process as new therapeutic modalities 
are being developed and new imaging and surgical approaches are applied. In those countries where med-
ical research and more prognostic information has become available, in recent years, new knowledge has 
boomed.  
A constantly evolving process is also being applied in surgery techniques. The term “radical” or 
“extended” hysterectomy encompasses various types of surgery. Since the first publications of large se-
ries of surgeries for cervical cancer by Wertheim in Austria (Wertheim, 1912) and later by Okabayashi in 
Japan (Okabayashi, 1921) and Meigs in the USA (Meigs, 1944), many radical procedures according with 
different degrees of radicality have been described and performed.  
The problem with all these procedures is that they name the same anatomical structures differently 
and define these structures according to different anatomic interpretations. In this scenario, the Piver–
Rutledge–Smith classification published in 1974 has achieved substantial popularity (Piver et al., 1974). 
It describes five classes of radical hysterectomy (Symmonds, 1975) including a class I category, which is 
not radical hysterectomy, and a class V category, which is no longer used. The rationale and anatomic 
definitions for differentiation between class III and IV are unclear. Surgeons frequently need to define 
intermediate classes inbetween classes II and III (eg, II-III or II-and-a-half). The original paper does not 
refer to clear anatomical landmarks or international anatomical definitions. The vaginal extent of resec-
tion is systematically attached to the pericervical extent; vaginal resection is excessive—from a third to 
three-quarters of the vagina.  
The classification by Piver et al. (1974) does not take into account the idea of nerve preservation 
that was introduced in the 1950s (Kobayashi, 1961) and subsequently refined by Japanese surgeons (Fujii 
et al., 2007; Sakuragi et al., 2005) and adopted by European surgeons (Raspagliesi et al., 2004; Trimbos 
et al., 2001). The Piver–Rutledge–Smith classification applies to open surgery only. Querleu & Morrow 
(2008) recently published a new radical hysterectomy classification, based, for simplification’s sake, on 
only the lateral extent of uterine resection. 
Only four types of radical hysterectomy are described, adding a few subtypes when necessary. In-
stead of the classification by Piver et al. (1974), stable anatomical landmarks are used to define the limits 
of resection. To make a clear distinction with the Piver–Rutledge–Smith, in the Querleu and Morrow 
classification (Querleu et al., 2008) letters are used rather than numbers to define classes. Simple hyster-
ectomy is not included in the classification. Lymph-node dissection, an essential part of surgical cervical 
cancer management, is considered separately. For lymph-node dissections, the limit between level 1 and 
level 2 is the bifurcation of the common iliac artery; the limit between level 2 and level 3 the bifurcation 
of the aorta; and the limit between level 3 and level 4 the inferior mesenteric artery. 
3    History and Evolution of Surgery in Cervical Cancer 
The ancient Egyptians used bamboo knives and in ancient India volcanic glass, obsidian, was used to op-
erate on patients. Over 1,000 years later until now, steel scalpels have been used to perform surgery. Only 
200 years ago, in 1809, the first documented laparotomy was performed for a gynaecological tumour by 
Ephraim McDowell, who removed an ovarian cyst. 
Since the late nineteenth century until now, surgery, and in particular radical surgery, has taken an 
astonishingly conservative approach. The same technique for radical cervical surgery surgery as intro-
duced by Wertheim in 1896 (Wertheim, 1912) is still being used today, and gynaecological oncological 
surgeons are very reluctant to change even minor details of this operation. Essentially, radical gynaeco-
logical surgery has remained fairly standard and unchanged. Although a first attempt at laparoscopy, on 
his dog, was made by Georg Kelling in 1901, it took until the 1970s for laparoscopy to be introduced into 
gynaecological surgery. In the beginning, it was only used for diagnostic purposes and sterilizations. As 
recently as 1989, the first series of ‘laparoscopically assisted vaginal hysterectomy’ were reported by 
Harry Reich (Reich & DeCaprio, 1989).  
Two years earlier, Dargent (1987) had described the use of laparoscopy as ‘presurgical retroperi-
toneal pelviscopy for Schauta’s operation’ in preparation for the vaginal approach for cervical cancer. In 
1992, Nezhat (1992) performed the first laparoscopic radical hysterectomy with pelvic and para-aortic 
lymph node dissection. In 2000, Dargent et al. (2000) reported successful laparoscopic vaginal radical 
trachelectomy and pelvic lymphadenectomy for young women with cervical cancer, who wanted to pre-
serve their fertility. In 2000, Possover et al. (2000) reported modified laparoscopic nerve sparing type III 
radical hysterectomy for cervical cancer and found that this procedure decreased postoperative bladder 
dysfunction incidence subsequently Pomel et al. (2003) evaluated, in a series of 50 consecutive patients, 
the feasibility, morbidity, and survival outcome of laparoscopic radical hysterectomy for carcinoma of the 
uterine cervix. 
With technical advances and emerging devices, as well as accumulating experience in laparoscop-
ic surgery, some surgical procedures that are difficult to carry out even by traditional open procedures can 
be performed successfully by laparoscopy. The major advantages associated with minimally invasive lap-
aroscopy are, amongst others, lower intraoperative bleeding rates, less post-operative pain, a shorter re-
covery time and a shorter hospital stay.  
In addition, the optical devices used for laparoscopic surgery feature a 10 to 15 times magnification and, 
therefore, provide an excellent view of pelvis anatomy.  
During the past decade some reports, on a limited number of patients, have shown the feasibility 
of radical resection by laparoscopic surgery and have documented an equivalent number of pelvic nodes 
harvested by laparoscopy and open surgery (Canis et al., 1995; Hsieh et al., 1998; Kim et al., 1998; 
Krause et al., 1995; Pomel et al., 1997; Sedlacek et al., 1994; Spirtos et al., 1996). Nevertheless, few 
long-term data on the morbidity and survival after laparoscopic radical hysterectomy are available. In gy-
necological oncology laparoscopic surgery does not substantially reduce tissue trauma, which makes it 
possible for extensive and complex operative procedures to be performed through small incisions, reduc-
ing intra-operative blood loss and impact on the body as well as common surgical complications. In addi-
tion, laparoscopic surgery is superior to conventional surgery with regard to postoperative mental rehabil-
itation in gynecological oncology patients.  
From the original publications on this radical hysterectomy surgery, surgical technique has aimed 
at a re-classification including a variety of techniques via laparotomy (Averette et al., 1993; Magrina et 
al., 1999), then via laparoscopy, resulting in reasonable morbidity with similar surgical outcomes (Abu-
Rustum et al., 2003; Magrina, 2005). However, longer operating times, steep learning curves, and lack of 
training have prevented laparoscopic treatment from becoming a widely adopted surgical approach to 
radical hysterectomy (Boggess, 2007; Ramirez et al., 2006). Although open radical hysterectomy is still 
considered the gold standard for the treatment of early cervical cancer (Abu-Rustum et al., 2001), laparo-
scopic radical (LRH) and laparoscopy-assisted radical vaginal hysterectomy (LARH) are evolving as po-
tential surgical alternatives. The principles are: to resect tumor and its surrounding tissues en bloc, to use 
tumor-free techniques when manipulating tumors, to preserve sufficiently incised margins, and to per-
form complete pelvic lymphadenectomy. Lymph node status is the most important prognostic factor in 
gynecologic tumor and surgical removal of the pelvic. Para-aortic lymph nodes for histological assess-
ment are part of gynecologic malignancies staging. Hence, laparoscopic surgery is consistent with the 
concept of minimally invasive surgery, i.e., smaller trauma, milder pain or analgesia, better homeostasis, 
more accurate operative outcomes, shorter hospital stay and better psychological effects than current 
standard open surgery. As a technical innovation, laparoscopic techniques for gynecological oncology do 
not change gynecological oncological surgery fundamentally, but they have improved surgical techniques 
for gynecological oncology in many aspects, and enhanced the efficacy of surgical cervical cancer treat-
ment. 
Additionally, removal of bulky lymph nodes may have therapeutic benefit. According to the re-
quirement by established FIGO classification systems, a different range of lymphadenectomy will be per-
formed depending on the different type of tumor present. The range of lymphadenectomy, consistent with 
that of open abdominal surgery, depends on cervical cancer disease. Lymph nodes, para-aortic and iliac 
vessels are resected within the vessel sheath. Obturator and deep inguinal lymph nodes, including lymph 
nodes below the obturator nerve, must be resected radically. 
The indication for laparoscopic surgery was similar to open surgery in cervical cancer patients. 
According to literature and our experience, the indication for laparoscopic radical hysterectomy (type III) 
and pelvic lymphadenectomy was earlier than the FIGO stage IIa in cervical cancer (Malzoni et al., 
2004). The indication for this surgical procedure is mainly influenced by the experience of the surgeon 
(Lecuru et al., 1998). More recently, it was reported that stage IIb or more advanced cervical cancer may 
be treated with type IV radical hysterectomy under laparoscopy (Chen et al., 2008; Possover et al., 1998; 
Querleu et al., 2008), as the aim of surgery is to stage and radically resect the tumor (including metasta-
ses). For certain patients, prolong survival is the objective of tumor treatment. 
4 Laparoscopic and Robotic-assisted Approaches in Gynaecological Ma-
lignancies 
The goal of laparoscopic surgery is to duplicate traditional open procedures via small incisions in the skin 
with surgical outcomes equivalent or superior to a traditional surgical approach. Laparoscopy offers mul-
tiple advantages in the management of malignancy, including smaller incisions, shorter hospital stay, 
quicker recovery, improved visualization, less need for postoperative analgesics, and a lower risk of 
complications, such as blood loss, wound infection, herniation, and ileus. These characteristics may prove 
particularly important in the setting of oncology where a shorter recovery period may facilitate a shorter 
interval to postoperative treatments such as chemotherapy or radiation. Laparoscopy also has its limita-
tions. Disadvantages include a long learning curve, counterintuitive motions, and limited depth percep-
tion as imaging is limited to 2-dimensional views. 
In an effort to overcome these limitations, multiple innovations have evolved over the last decade. 
Laparoscopic instrumentation has expanded to include several different vessel sealing devices with inte-
grated cutting capabilities, endoscopic staplers, articulating instrument tips, 3-dimensional capabilities, 
and computer-enhanced technology in the form of robotics. Therefore, robotic surgical systems seem to 
be the future in gynecologic surgery, since robotic technology can improve accuracy, enhance dexterity, 
and provide for faster suturing and a lower training curve than laparoscopy. All of this makes gynecolog-
ic surgeons tend to perform a greater number of gynecologic procedures by robotic approach, when avail-
able. In the last five years, a large number of robotic surgery related papers have been published, both for 
benign and oncological cases, which is proof of the rapid spread and high acceptance of this new technol-
ogy. 
Gynecological oncology probably presents the optimal forum for application of robotics, given 
the complexity of surgical steps involved in performing radical hysterectomies for cervical cancer and 
lymph node sampling for endometrial cancer. Radical hysterectomy was one of the first indications for 
robot-assisted laparoscopy, as this made it possible to perform a complex and long procedure laparoscop-
ically. Studies comparing the results of robot-assisted and conventional laparoscopic surgery yielded 
slightly different but conflicting results. Boggess et al. (2008) found a rate of 7.8 % for major complica-
tions after robotic surgery, compared with 16.3 % after conventional laparoscopic surgery, whereas 
Kruidenberg et al. (2011) found just the opposite, with 9.6 % and 5.5 %, respectively (statistically signif-
icant differences in both studies). Survival after both modalities seems to be similar. 
 
5    The History of Laparoscopy in Cervical Cancer 
In 1989, Querleu et al. (1989) performed the first laparoscopic pelvic lymphadenectomy for cervical can-
cer, then, in 1990, Canis et al. (1990) described a totally laparoscopic radical hysterectomy. In 1991, 
Querleu et al. (1991) reported laparoscopic pelvic lymphadenectomy and vaginal assistant radical hyster-
ectomy for early cervical cancer. In 1992 and in 1993, Nezhat et al. (1992; 1993) reported the first case of 
cervical cancer treated with laparoscopic radical hysterectomy and pelvic lymphadenectomy. Since then, 
the techniques have been applied clinically and achieved satisfactory clinical outcomes, Vaginal radical 
trachelectomy and laparoscopic pelvic lymphadenectomy were done by Dargent et al. (1996). 
In 2000, Possover et al. (2000) reported modified laparoscopic nerve sparing type III radical hys-
terectomy for the treatment of cervical cancer, and found that this procedure decreased the incidence of 
postoperative bladder dysfunction. In 2003, Pomel et al. (2003) reported the feasibility, morbidity, and 
survival outcome of the laparoscopic radical hysterectomy for carcinoma of the uterine cervix, operated 
between 1993 and 2001 at two cancer centers. Thirty-one patients had prior brachy therapy. The median 
overall operative time was 258 min. The mean number of harvested pelvic external iliac nodes was 13.22 
per patient. The median postoperative hospital stay was 7.5 days. Two patients had major urinary compli-
cations; one had a bladder fistula and one ureteral stenosis. Median follow-up was 44 months. Overall 5-
year survival rate of FIGO stage Ia2 and Ib1 patients was 96%. Their results demonstrated that radical 
hysterectomy can be performed by laparoscopy in stage IB1 or less advanced node negative cervical can-
cer patients without compromising survival; moreover, prior brachytherapy did not affect the feasibility 
of this radical procedure. 
With technical advances and emerging devices, as well as accumulating experience in laparoscop-
ic surgery, some surgical procedures that are difficult to carry out even by traditional open procedures can 
be performed successfully by laparoscopy. During the past decade some reports, on a limited number of 
patients, have shown the feasibility of a radical resection by laparoscopic surgery and have documented 
an equivalent number of pelvic nodes harvested by laparoscopy and open surgery (Gil-Ibáñez et al., 
2013; Kho et al., 2009; Krause et al., 1995; Pomel et al., 1997; 2003; Sedlacek et al., 1994). Neverthe-
less, few long-term data on the morbidity and survival after laparoscopic radical hysterectomy are availa-
ble. Although open radical hysterectomy is still considered the gold standard for the treatment of early 
cervical cancer (Spirtos et al., 1996), laparoscopic radical (LRH) and laparoscopy assisted radical vaginal 
hysterectomy (LARH) are evolving as potential surgical alternatives.  
LRH or LARH have been established as standard procedures routinely performed as first line 
therapy for the treatment of early cervical cancer at specialized centers (Hatch, 1996; Kohler et al., 2004; 
Obermair et al., 2003; Pomel et al., 2003). The major advantages associated with minimally invasive lap-
aroscopy are, amongst others, lower intraoperative bleeding rates, less post-operative pain, a shorter re-
covery time and a shorter hospital stay. In addition the optical devices used for laparoscopic surgery fea-
ture a 10 to 15 times magnification and, therefore, provide an excellent view of pelvis anatomy. Since 
Liang et al. reported their initial experience with 57 LRH; they have continuously improved and stand-
ardized the technique (Liang et al., 2006; Querleu, 1990). The indication for laparoscopic surgery was 
similar to the indication for open surgery in cervical cancer patients. According to literature and experi-
ence, the indication for laparoscopic radical hysterectomy (type III) and pelvic lymphadenectomy was 
earlier than the FIGO stage IIa in cervical cancer (Liang et al., 2006). However, initially, laparoscopic 
technique treatment of cervical cancer is associated with a high complication rate so the indication must 
be carefully assessed, and patients have to be counseled extensively prior to surgery. Apart from the size 
and stage of the tumor, the indication for this surgical procedure is mainly influenced by the experience 
of the surgeon (Malzoni et al., 2004). 
More recently, it was reported that stage IIb or more advanced cervical cancer may be treated with 
type IV radical hysterectomy under laparoscopy (Chen et al., 2008; Lecuru et al., 1998; Querleu & Mor-
row, 2008), as the aim of surgery is to stage and radically resect the tumor (including metastases). For 
certain patients, prolonged survival is the objective of tumor treatment. Through laparoscopic explora-
tion, the feasibility and thoroughness of surgery can be evaluated, and the relative benefits of surgery for 
the patient can be weighed. However, it is still controversial what types or what stages of cervical cancer 
should be adopted for laparoscopic surgical treatment. 
Another minimally invasive surgical option used for cervical cancer is laparoscopically assisted 
vaginal radical hysterectomy (LAVRH) or Coelio-Schauta procedure. The Coelio-Schauta procedure 
consists of 2 major steps, 1 laparoscopic and 1 transvaginal. Four trocars are inserted, 1 transumbilical, 2 
lateral to the inferior epigastric vessels, and 1 in the right lower abdomen. Traditionally, laparoscopy has 
been used to develop the paravesical and pararectal spaces and to perform lymphadenectomy of iliac ves-
sels. In the transvaginal step, the urinary bladder is dissected from the cervix, the posterior cul-de-sac is 
opened, and the ureters are identified before their insertion into the bladder pilar; then the uterine arteries 
are ligated, and the cardinal ligaments are transected 3 cm from the cervix. Ligation of the utero-ovarian 
ligaments (or the infudibulopelvic ligaments if ovarian preservation is not mandated) is then performed, 
the round ligament is resected, and the specimen is extracted (Schneider et al., 1996).  
A recent review of Pergialiotis et al (2013) on LAVRH on Medline (1966-2013) and Scopus 
(2004-2013), as well as on reference lists from all included studies, retrived 10 studies: including 6 retro-
spective cohort studies, 2 prospective cohort studies, 1 retrospective randomized trial, and a phase II ran-
domized control trial.LAVRH provided equal recurrence-free rates when performed in patients with tu-
mors not exceeding 2 cm in greatest diameter. Its main advantages seem to be less intraoperative blood 
loss and more radical pelvic lymphadenectomy. The primary disadvantages of the technique are a higher 
rate of disease-positive surgical margins, resulting in the need for adjuvant therapy, and the slow learning 
curve required for a surgeon to gain expertise. 
6    Total Laparoscopic Radical Hysterectomy for Cervical Cancer 
Laparoscopy can be safely and adequately used in the treatment of endometrial, ovarian and cervical can-
cer (Possover et al., 1998). In the setting of gynecologic oncology, laparoscopic approaches have been 
implemented in radical hysterectomy. For gynecological oncology laparoscopic surgery is an important 
step forward combining scientific, technological and surgical techniques, which not only enhance the ef-
ficacy of surgical treatment of gynecological oncology, but are also superior to conventional open surgery 
with regard to postoperative mental rehabilitation in gynecological oncology patients. The first total lapa-
roscopic radical hysterectomy with lymphadenectomy was reported in June 1989 by Nezhat et al. (1992). 
Since then, more than 600 cases of total laparoscopic radical hysterectomy have been reported. A recent 
prospective case-control series compared total laparoscopic radical hysterectomy with abdominal radical 
hysterectomy and found shorter hospital stays and lower blood loss as well as a statistically significantly 
higher nodal yield among total laparoscopic radical hysterectomy cases (Zakashansky et al., 2007). 
Spirtos et al. (2002) described 78 patients with early-stage cervical cancer undergoing laparoscop-
ic radical hysterectomy. In that series, 94% of the procedures were completed laparoscopical.Mean fol-
low-up time was 67 months. Mean operative time was 205 min, and mean blood loss was 225 mL. One 
patient required a blood transfusion, three patients had unintended cystotomies, two patients required lap-
arotomy to control bleeding, and one patient suffered an ureterovaginal fistula. Three patients had micro-
scopically positive or close margins. The authors reported a cervical cancer recurrence rate of 5%. 
Pomel et al. (2003) reported 50 patients with stage IA1–IB1 cervical cancer who underwent total 
laparoscopic radical hysterectomy. The median operating time was 258 min, and the mean number of 
lymph nodes harvested was 13. No conversions to laparotomy were reported. Median hospital stay was 
7.5 days. The authors reported that 10 patients had early complications (within 2 months of surgery) and 
that three of those patients required reoperation. They also reported three patients had late complications 
(more than 2 months after surgery) two of them requiring reoperation. Three patients experienced recur-
rence with a median follow-up time of 44 months. 
Frumovitz et al. (2007) compared 35 patients undergoing total laparoscopic radical hysterectomy 
with 54 undergoing total abdominal radical hysterectomy. Mean estimated blood loss was significantly 
lower in the laparoscopic-surgery group than in the open-surgery group (319 vs. 548 mL; p=0.009). Mean 
operative time was significantly longer with laparoscopic surgery (344 vs. 307 min; p=0.03), but median 
hospital stay was significantly shorter (2.0 vs. 5.0 days, pb0.001). Postoperative infections were much 
less common after laparoscopic surgery (18% vs. 53%; p=0.001). Notwithstanding the obvious ad-
vantages of conventional laparoscopy, recent surveys of practicing gynecologic oncologist revealed that 
most respondents believed minimally invasive surgery by conventional laparoscopy had only a minimal 
role in the management of cervical cancer (Fastrez et al., 2009). 
Puntambekar et al. (2007) reported a retrospective review of 248 patients with FIGO stage Ia2 
(n=32) and Ib1 (n=216) cervical cancer who underwent a TLRH (type III) with bilateral pelvic lymphad-
enectomy, which is the largest single-institution study. The operation was performed entirely by laparos-
copy in all patients and by the same surgical team. Median operative time was 92 min. Median number of 
resected pelvic nodes was 18. Median blood loss was 165 ml. Median duration of hospital stay was 3 
days. None of the patients required conversion to laparotomy. Seventeen patients had complications with-
in 2 months of surgery. Seven patients had recurrences after a median 36-month follow-up. They con-
cluded that TLRH can be performed safely, reduces morbidity associated with ARH and is an easily rep-
licable technique. 
Colombo et al. (2009) evaluated surgical outcome and oncologic results of total laparoscopic rad-
ical hysterectomy (TLRH) after neoadjuvant chemoradiation therapy (CRT) for locally advanced cervical 
carcinoma. All patients who underwent TLRH after CRT for stages IIB–IIA and bulky IB diseases were 
reviewed. The control group for this analysis was a cohort of patients treated with abdominal radical hys-
terectomy (ARH) after CRT for the same stage cancers. They reviewed 102 patients operated on between 
2000 and 2008 (46 TLRH and 56 ARH). Mean age at diagnosis was 44 years, and mean B.M.I was 22.1. 
There was no difference in tumor characteristics between the two groups. Seven patients in the laparo-
scopic group required conversion to laparotomy (15%). Mean estimated blood loss (200 vs. 400 mL, 
pb0.01) and the median duration of hospital stay (5 vs. 8 days, p<0.01) were significantly lower in the 
laparoscopic group. Morbidity rates and urinary complications were reduced in the laparoscopic group 
(p=0.04). Local recurrence rates, disease-free and overall survival were comparable in the two groups. 
Best survival was observed for patients with pathological complete response or microscopic residual dis-
ease compared to patients with macroscopic residues (pb0.01). Authors concluded that radical hysterec-
tomy after CRT, with significant morbidity rates, is known to be difficult and remains controversial in 
comparison to exclusive CRT. TLRH after preoperative CRT is feasible in 85% of the cases for patients 
with locally advanced cervical cancer. For these patients, TLRH compared with ARH was associated 
with favorable surgical outcome with comparable oncological results. 
Although laparoscopic surgery has many advantages, it is also associated with a number of poten-
tial drawbacks, including limited range of intra-abdominal motion (only 4° of freedom), counterintuitive 
movements, amplification of tremors in prolonged cases due to the length and rigidity of the instrumenta-
tion, and reduced depth perception secondary to a two-dimensional view. Naturally, total laparoscopic 
radical hysterectomy is not without its risks and complications. 
There are still several new challenges to be met regarding theory and enhancement of surgical 
skils (Persson et al., 2008). Firstly, to form a laparoscopic surgical team, a lot of special requirements re-
lating to both the team members and the equipment have to be met, thus restricting the popularization of 
laparoscopic radical hysterectomy. Secondly, every detail should be taken into careful consideration, 
risks should be balanced and benefits ascertained before performing laparoscopic procedures. Moreover, 
it is likely that well-known barriers to the implementation of advanced minimally invasive procedures 
such as association with a long learning curve, lack of training, complexity of the operations, limitation of 
technology and instrumentation, and the necessity of an expert assistant were responsible for this senti-
ment. For these reasons, only a few surgeons have adopted a laparoscopic approach to type III cervical 
cancer radical. There are issues with the length of the procedure, as type III laparoscopic hysterectomies 
take significantly longer than open cases. Furthermore, intraoperative complications of the urinary tract 
(for example as a result of thermal injuries) tend to be much more common in laparoscopic than in open 
cases (Xu et al., 2007). 
A recent experience of Malzoni et al. (2009) on 71 patients treated by total laparoscopic radical 
hysterectomy (type II, III) with lymphadenectomy was done between January 2000 and March 2008. The 
authors concluded that total laparoscopic radical hysterectomy can be considered a safe and effective 
therapeutic procedure for the management of early stage cervical cancer with a low morbidity, offering an 
alternative option for patients undergoing radical hysterectomy, although multicenter studies and long-
term follow-up are required to evaluate the oncologic outcomes of this procedure. 
A literature review on laparoscopic radical hysterectomy demonstrates the procedure is also safe 
and feasible, but is associated with an operative time range of 205 min–371 min, an estimated blood loss 
of 200 cc–445 cc, a nodal yield ranging from 13–25, a hospital stay ranging from 1–7.5 days, and an 
overall complication rate of 11%–20%, as sorted by the referenced papers who provide a good cross sec-
tion of the data (Abu-Rustum et al., 2003; Magrina, 2007; Pomel et al., 2003; Ramirez et al., 2006; Spir-
tos et al., 1996; 2002). 
7   Contra-indications to Laparoscopic Surgery for Gynecological Oncol-
ogy 
As previously noted, there are very few absolute contra-indications. However, with increased anesthesia 
ability, some of these may not be considered as absolute. Severe cardiac diseases could be a problem, 
since some patients may not tolerate the operation due to the deep Trendelenburg positions necessary dur-
ing most operative laparoscopy in order to maintain an adequate pneumoperitoneum. Severe patient liv-
er/renal/respiratory dysfunction, which cannot be corrected preoperatively, is also considered to be an ab-
solute contraindication. 
Surgeons may refuse laparoscopy for advanced or late stage gynecological tumor in patients with 
stage III or above cervical carcinoma, lymph node metastases of cervical cancer which inter-fuse and en-
capsulate vital vessels, and/or extensive infiltration of adjacent tissues. On the other hand, there are few 
relative contra-indications to laparoscopy for cervical cancer patients; for example, severe abdominal ad-
hesions or morbid obesity and so on. 
8    Total Robotic-assisted Laparoscopic Radical Hysterectomies 
Today there is only one U.S. Food and Drug Administration approved device for surgical robotics. This 
current robotic platform is known as the "da Vinci" surgical system, developed by Intuitive Surgical, Inc. 
(Intuitive Surgical, Mountain View, CA, USA). The da Vinci surgical system is equipped with a 3-
dimensional vision system in which double endoscopes generate two images resulting in perception of a 
3D image. In addition, with the development of endowrist, it reproduces the range of motion and dexteri-
ty of the surgeon hand, providing high precision, flexibility and the ability to rotate instruments 360 de-
grees. Thus, the learning curve of achievement for the surgeons using the da Vinci surgical system was 
shortened. In 2001, a more advanced da Vinci surgical system with four robotic arms gained US FDA 
approval and is now being used in many surgical procedures throughout the world. 
Recently, FDA-approved robotic surgery has become an option in the definitive surgical man-
agement of early stage cervical cancers. Several case series about robotic-assisted radical hysterectomies 
for cervical cancer have now been published (Boggess, 2007; Kim et al., 2008; Magrina et al., 2008; Ma-
grina, 2007; Malzoni et al., 2004; 2009). 
The initial experience and the first publications on robot assistance in gynecological oncology 
date from recent years.  In February, 2006, Boggess (2005) performed the first live telecast, demonstrat-
ing a technique for performing robotic-assisted radical hysterectomy and subsequently presented data for 
a series of 13 radical hysterectomies at the Society of Gynecologic Oncologists annual meeting in March 
of the same year. Since this initial demonstration of feasibility and technique, the interest in robotic-
assisted gynecologic oncology procedures has spread rapidly.  
Recently, Nezhat et al. (2008) prospectively compared the outcomes of 13 total robotic-assisted 
laparoscopic radical hysterectomies to 30 cases of traditional total laparoscopic radical hysterectomy with 
pelvic lymphadenectomy in patients with stage IB to IIA cervical cancer. There was no difference in op-
erative time, hospital stay, blood loss, complications, or number of nodes retrieved. This study suggests 
that robotic radical hysterectomy may be a feasible alternative to total laparoscopic radical hysterectomy 
(unpublished data). However, there were no advantages of robotic-assisted procedures compared to tradi-
tional total laparoscopic radical hysterectomy when performed by an experienced laparoscopic gyneco-
logic oncologist. 
Fanning et al. (2008) reported the first series of robotic radical hysterectomy on 20 women with 
stage IB–IIA cervical carcinoma. Median operative time was 6.5 hours, and median blood loss was 300 
mL.No complications were encountered, and all patients were discharged home on the first postoperative 
day. A retrospective cohort study of robotic vs. open radical hysterectomy found that the mean blood loss 
was significantly lower for the robotic group (81.9 vs. 665 mL, p<0.0001), but operative time was longer 
(4.5 vs. 3.39 hours, p=0.0002). The mean number of lymph nodes resected did not differ, and no compli-
cations were reported in the robotic assisted group (Ko et al., 2008). Furthermore, laparoscopic radical 
hysterectomy studies, although variable, report an operating times from 92 to 350 minutes, an estimated 
blood loss of 165 ml, and a length of stay of three days, whereas for robotic surgery comparable figures 
are 190-370 minutes, 140 ml, and two days (Decloedt & Vergote, 1999; Li et al., 2007; Possover et al., 
1998; Zakashansky et al., 2007). 
The first radical hysterectomy in cervical cancer with robot assistance was described by Sert and 
Abeler (2006). They concluded that radical dissection could be performed much more precisely than with 
conventional laparoscopy. In 2007, they described 15 women with early-stage cervical cancer as a pilot 
case–control study and compared robotic-assisted laparoscopic radical hysterectomy with conventional 
total laparoscopic radical hysterectomy. There was a significant difference in mean operating time (241 
minutes in the robot group and 300 minutes in the conventional group). No difference in the number of 
lymph nodes and size of parametrial tissue was found. In the robot group, there was significant less 
bleeding and shorter hospital stay. 
Kim et al. (2008) performed robotic radical hysterectomy and pelvic lymphadenectomy in ten 
cases and found a mean operating time of 207 minutes. The mean docking time was 26 minutes, but this 
was reduced significantly with experience (from 35 to 10 minutes). These small series, however, do not 
report the outcome of surgery in terms of lymph node yield and radicality and also lack sufficient onco-
logical follow up.  
Boggess et al. (2008) found no difference in the operating time (242 versus 240 minutes). He per-
formed 13 robot-assisted radical hysterectomies and compared them with 48 open radical hysterectomies. 
Significantly more lymph nodes were collected in the robot group (33 versus 22). All the robotic patients 
were discharged within 24 hours. He also describes how to set up a robotic program in gynaecological 
oncology.  
Recently, a study of Lowe et al. (2009) reported a multi-institutional experience with robotic-
assisted radical hysterectomy in patients with early stage cervical cancer with respect to peri-operative 
outcomes. In their investigation, a multi-institutional robotic surgical consortium consisting of five board-
certified gynecologist oncologists in distinct geographical regions of the United States was created, in or-
der to evaluate the utility of robotics for gynecologic surgery (benign and malignant). Between April 
2003 and August 2008, a total of 835 patients underwent robotic surgery for benign gynecologic disor-
ders and/or gynecologic malignancies by a surgeon in the consortium. For the purpose of the study, a 
multi-institutional HIPPA compliant database was then created for all patients. In the results, from a da-
tabase of 835 patients who underwent robotic surgery by a gynecologic oncologist they identified, a total 
of 42 patients who underwent a robotic-assisted type II (n=10) or type III (n=32) radical hysterectomy for 
early stage cervical cancer. With regard to stage, seven patients (17%) were Stage IA2, twenty-eight pa-
tients (67%) were Stage IB1 and six patients (14%) were Stage IB2. There was a single patient with Stage 
IA1 cervical cancer with vascular space invasion who underwent type II radical hysterectomy. Overall 
median operative time was 215 min. Overall median estimated blood loss was 50 cc. No patient received 
a blood transfusion. Median lymph node count was 25. Median hospital stay was 1 day. Positive lymph 
nodes were detected in 12% of the patients. Pelvic radiotherapy or chemo-radiation was given to 14% of 
the patients based on final surgical pathology. Intraoperative complications occurred in 4.8% of the pa-
tients and included one conversion to laparotomy (2.4%) and one ureteral injury (2.4%). Postoperative 
complications were reported in 12% of patients and included a DVT (2.4%), infection (7.2%), and blad-
der/urinary tract complication (2.4%) Conversion rate to laparotomy was 2.4%. In their conclusions, 
Lowe et al. reported that robotic-assisted radical hysterectomy is associated with minimal blood loss, a 
shortened hospital stay, and few operative complications. Operative time and lymph node yields are ac-
ceptable. This data suggests that robotic-assisted radical hysterectomy may offer an alternative to tradi-
tional radical hysterectomy.  
Persson et al. (2009) reported their experience in 80 robot-assisted laparoscopic radical hysterec-
tomies to evaluate its feasibility and morbidity, from December 2005 to September 2008. They used a 
prospective protocol, and an active investigation policy to define adverse events, perioperative, and short 
and long term data. Also in their conclusions, authors showed that robot- assisted laparoscopic radical 
hysterectomy could be a feasible alternative to conventional laparoscopy and open surgery, even if efforts 
should be made to ensure proper closure of the vaginal cuff, trocar sites and to develop nerve sparing 
techniques. 
Cantrell et al. (2010) assessed progression-free and overall survival for women with cervical can-
cer who underwent type III robotic radical hysterectomy, in a retrospective analysis of women who un-
derwent RRH from 2005 to 2008. They were compared to a group of historical open radical hysterecto-
mies. They analyzed seventy-one women who had undergone attempted RRH during the study period. 
Eight were excluded from analysis: 4 for non-cervical primary and 4 cases were aborted due to the extent 
of the disease. Squamous was the most common histology (62%) followed by adenocarcinoma (32%). 
Median patient age was 43 years. There was one intraoperative complication (asystole after induction) 
and two postoperative complications (ICU admission to rule out myocardial infarction and reoperation 
for cuff dehiscence). Of the patients who underwent RRH, 32% received whole-pelvis radiation with 
chemo sensitization. Median follow-up was 12.2 months (range 0.2–36.3 months). Kaplan–Meier surviv-
al analysis demonstrated 94% PFS and OS at 36 months due to recurrence and the death of one patient. 
As compared with a historical cohort at our institution, there was no statistically significant difference in 
PFS (P=0.27) or OS (P=0.47). In the conclusions, Cantrell et al. reported that RRH is safe and feasible 
and has been shown to be associated with improved operative measures. This study showed that at 3 
years, RRH appears to have PFS and OS equivalent to that of traditional laparotomy. While the 5-year 
data are not yet available for the cohort of patients treated with robotic surgery, the 94% survival upon 3 
years of performing RRH is comparable to other surgical methods and radiation. 
9    The problem of Lymph-node in Endoscopic Lymphadenectomy 
The limitations of FIGO clinical staging involve the possibility to detect metastases to lymph nodes, us-
ing clinical staging alone. This leads to under staging of some patients (Lagasse et al., 1980; LaPolla et 
al., 1986). Failure to detect metastasis to para-aortic nodes in patients with locally advanced cervical can-
cer leads to suboptimal treatment. One option consists of evaluating lymph node invasion using imaging 
techniques. However, as reported recently, false negative rates as high as 11% have been reported when 
comparing PET to lymphadenectomy in advanced cervical cancer (Mortier et al., 2008). Ramirez et al. 
compared positron emission tomography (PET)/computed tomography (CT) with laparoscopic extraperi-
toneal staging in the evaluation of para-aortic lymph nodes. The sensitivity and specificity of PET/CT in 
detecting positive para-aortic nodes when nodes were negative on CT or MRI were 36% and 96%, re-
spectively. The PPV and NPV of PET/CT for para-aortic metastasis were 71% and 83%, respectively. For 
the subset of patients with positive pelvic lymph nodes on preoperative PET/CT, the sensitivity of 
PET/CT for identifying para-aortic lymph node metastases was 45%, the specificity was 91%, the PPV 
was 71%, and the NPV was 78% (Pecorelli et al., 2009). Therefore, another option is to perform surgical 
staging (Kohler et al., 2004; Marnitz et al., 2005; Possover et al., 1998). 
Laparoscopic para-aortic node sampling has been shown to be feasible in gynecological malig-
nancies. In addition, it is associated with lower morbidity than staging using laparotomy (Dargent et al., 
2000; Denschlag et al., 2005; Querleu et al., 1993; 2000; Spiritos et al., 1995; Vergote et al., 2002). Its 
only technical limitation occurs in obese patients. However, using the classical laparoscopic approach, the 
surgeon is limited in the degrees of his movements. By assisted-robotic surgery, this problem could be 
solved. The feasibility of a robotically assisted retroperitoneal approach, to dissect lower lumbo-aortic 
lymph nodes, was reported recently. Simultaneously to Vergote et al. (2008), Fastrez et al. (2009), evalu-
ated the feasibility and safety of a robot-assisted laparoscopic transperitoneal approach of the para-aortic 
lymph node dissection on 8 patients with advanced cervical carcinoma who were eligible for primary 
pelvic radiotherapy combined with concurrent cisplatin chemotherapy or pelvic exenteration and who un-
derwent a pre-treatment robot assisted transperitoneal laparoscopic para-aortic lymphadenectomy. Au-
thors isolated from 1 to 38 para-aortic nodes per patient and had one para-aortic node positive patient 
who was treated with extended doses of pelvic radiotherapy. We did not encounter any major complica-
tions and post-operative morbidity was low. In the conclusions, Fastrez reported that robot assisted trans-
peritoneal laparoscopic para-aortic lymphadenectomy is feasible and provides the surgeon with greater 
precision than classical laparoscopy, even if larger prospective multicentre trials are needed to validate 
the generalized usefulness of this technique. 
The technique of the robotic retroperitoneal para-aortic lymphadenectomy has been described by 
Vergote et al. (2008), who reported the feasibility of robot-assisted laparoscopic retroperitoneal para-
aortic lymphadenectomy in five patients. 
In 2008 Ramirez et al. (2008) described a series of patients diagnosed with invasive cervical can-
cer after undergoing simple hysterectomy who subsequently underwent robotic radical parametrectomy 
and bilateral pelvic lymphadenectomy. In their results, authors included 5 patients in analysis, with inva-
sive squamous cell carcinoma of the cervix. There were no conversions to laparotomy. There was 1 in-
traoperative complication—cystotomy. No patient required blood transfusion. The mean duration of hos-
pital stay was 1 day (range, 1 to 2). One patient experienced two postoperative complications, a vesico-
vaginal fistula and a lymphocyst. No patient had a residual tumor in the parametrectomy specimen, and 
no patient underwent adjuvant therapy. Median number of pelvic lymph nodes removed was 14 (range, 6 
to 16). Median follow-up for all patients was 7.5 months (range, 1.3 to 13.8), without recurrences. In con-
clusion, Ramirez assessed that robotic radical parametrectomy and bilateral pelvic lymphadenectomy is 
feasible and safe and can be performed with an acceptable complication rate. 
Robotic assistance with the Da Vinci system provides the surgeon with more precise dissection 
conditions, thanks to the three-dimensional visualization, instrumentation with articulating tips, that al-
lows the surgeon's hands more mobility and decreases tremor movements. This increased precision in 
procedure as compared with classical laparoscopy is particularly important in the para-aortic region and 
may enhance safety and decrease intraoperative morbidity. 
10    Fertility-sparing Surgery in Cervical Cancer 
The incidences of cervical cancer are increasing in young women and women are delaying their 
childbearing. Available literature shows that there are interesting fertility-sparing treatment alternatives to 
the “golden standard” for the management of early cervical cancer in young women. So, the fertility-
sparing surgery becomes an option for young women affected by cervical cancer. Fertility-sparing sur-
gery can be offered to carefully selected patients with cervical cancer for the management of early-stage 
(IA or IB1) disease who wish to preserve fertility (Lange et al., 2013). Simple trachelectomy (cervicec-
tomy) and radical trachelectomy (resection of parametrial tissue with cervix) are being used in women 
with early stage disease. Cervical conization used in preinvasive cancer as investigative biopsy could also 
become a therapy. Randomized controlled trials of fertility-preserving surgery are impractical and unfea-
sible; however, radical trachelectomy has been retrospectively shown to have similar oncologic outcomes 
to radical hysterectomy in select patients with stage IB1 cervical cancer. In patients with stage IA1 cervi-
cal cancer, conization is a valid alternative. Patients with stage IA2-IB1 disease can be conservatively 
treated by radical trachelectomy. This is as well-established conservative approach and appears to be safe 
and effective in allowing a high chance of conception (Lange et al., 1986). 
Prematurity is the most serious issue in pregnancies following trachelectomy. Less invasive op-
tions such as simple trachelectomy or conization seem to be feasible for stages IA2-IB1, but more and 
better evidence is needed. Neoadjuvant therapy might allow conservative surgery to be performed, also in 
patients with more extensive lesions. Ovarian transposition is important when adjuvant radiation is need-
ed (Noyes et al., 2011).  
Trachelectomy has been adopted by many oncological centers all over the world with good onco-
logical and obstetric results. The selection of patients by adequate preoperative evaluation is an important 
process before a decision regarding conservative treatment is taken. Lesionextent is of great importance; 
the tumor should be small in size and confined to the cervix without parametrial invasion or spread to the 
uterine corpus. A 19% recurrence rate has been reported for patients with lesions >2 cm and 25% for 
those with lesions >2 cm and depth of invasion > 1 cm (Lambaudie et al., 2010	  Ramirez et al., 2008). 
Radical trachelectomy is performed in select patients diagnosed with early-stage cervical cancer 
who wish to preserve their fertility. Since the procedure was first described by Dargent et al. (1994), nu-
merous reports have documented the safety and feasibility of the vaginal approach (Beiner et al., 2008; 
Dursun et al., 2007; Hertel et al., 2006; Plante, 2008; Ungar et al., 2005). Alternatively, the procedure 
may also be performed successfully via the abdominal approach. Several groups have published works on 
the success rate and feasibility of the abdominal approach (Geisler et al., 2008; Pergialiotis et al., 2013). 
The first to report on robotic radical trachelectomy were Geisler et al. (2008), who reported on a 
patient with stage IB1 cervix adenosarcoma. In this case, total operative timewas 172 min, and the esti-
mated blood loss was 100 ml. No residual tumor was found in the surgical specimen, and all lymph nodes 
were negative for any evidence of disease . 
Persson et al. (2008) published on 2 patients who underwent robotic radical trachelectomy. One 
patient was diagnosed with a stage IB1 cervix adenocarcinoma and the other with a stage IA2 squamous 
cervix carcinoma. This group of investigators was the first to publish on robotic radical trachelectomy in 
conjunction with lymphatic mapping and sentinel node identification. In that study, console time was 387 
min for the first patient and 359 min for the second. Estimated blood loss was 150 ml for the first patient 
and 100 ml for the second. The authors reported no intraoperative complications. Neither patient had re-
sidual cancer or evidence of lymph node disease. 
Chuang et al. (2008) described a robotic radical trachelectomy in a young woman with cervical 
cancer who desired preservation of fertility; the patient had previously undergone a cervical conization 
procedure, with negative margins. Findings at positron emission tomography and computed tomography 
were normal, and there was no evidence of metastasis before surgery. The operation lasted 345 minutes, 
with 200 mL blood loss. Final pathologic analysis showed no evidence of residual cancer. All reported 
cases were completed successfully and highlight robotic-assisted laparoscopy as a useful approach to tra-
chelectomy in appropriate patients.  
As one could argue that parametrectomy is not necessary for small tumours, it is relevant that this 
approach allows one to tailor the extent of parametrectomy according to the size of the tumour. Potential-
ly, this minimally invasive approach may also overcome a severe disadvantage of abdominal trachelec-
tomy, namely that pregnancy rate is much lower than after vaginal radical trachelectomy, but series are as 
yet too small to assess this potential benefit. 
The robotic approach also seems safe in cases where surgery follows neoadjuvant chemotherapy 
for locoregional extensive tumours. In a study comparing robot-assisted laparoscopy, conventional lapa-
roscopy and laparotomy groups, there was no difference in the recurrence rate (27.3 %, 29.4 % and 30 %, 
respectively) (Burnett et al., 2009; Dargent et al., 1994). 
Ramirez et al. (2010) described their surgical technique in a retrospective review on 4 patients 
who underwent robotic radical trachelectomy and bilateral pelvic lymphadenectomy from October 2008 
to May 2009. Their analysis included 4 patients with early-stage squamous cell carcinoma of the cervix. 
The median body mass index was 27.1 kg/m2 (range, 22.7 to 39.1). Three patients had stage IA2 adeno-
carcinoma; 1 patient had stage IA1 adenocarcinoma with lymph-vascular space invasion. Median opera-
tive time was 339.5 min (range, 245 to 416). Median console time was 282.5 min (range, 217 to 338). 
Median estimated blood loss was 62.5 ml (range, 50 to 75). There were no conversions to laparotomy. 
There were no intraoperative complications. No patient required blood transfusion. The mean duration of 
hospital stay was 1.5 days (range, 1 to 2). One patient experienced a postoperative complication, transient 
left lower extremity sensory neuropathy. No patient had residual tumor in the trachelectomy specimen, 
and no patient underwent adjuvant therapy. The median number of pelvic lymph nodes removed was 20 
(range, 18 to 27). The median time to a successful voiding trial was 8 days (range, 7 to 9). The median 
follow-up was 105 days (range, 82 to 217). There were no recurrences. Ramirez et al. concluded that ro-
botic radical trachelectomy and bilateral pelvic lymphadenectomy is feasible and safe and should be con-
sidered for patients desiring fertility-sparing surgery. 
There is increasing evidence in literature that not only is radical trachelectomy feasible and safe 
but the oncologic outcomes are similar to those of equivalent patients undergoing radical hysterectomy.  
In a recent article, Diaz et al. (2008) compared the outcomes of 40 patients with stage IB1 cervical cancer 
who underwent radical trachelectomy and 110 patients with stage IB1 cervical cancer who underwent 
radical hysterectomy. The median follow-up time was 44 months. The 5-year recurrence-free survival 
rate was 96% for the radical trachelectomy group compared to 86% for the radical hysterectomy group 
(p=NS). The authors concluded that for select patients with stage IB1 cervical cancer, fertility-sparing 
radical trachelectomy appears to produce oncologic outcomes similar to those after radical hysterectomy. 
Recently, many studies analysed the reproductive outcome after fertility-sparing radical trachelec-
tomy. One of these studies was performed by Kim et al. (2012) on 105 patients who underwent RT. 77 
(73%) did not require a conversion to radical hysterectomy or postoperative treatment. Median age was 
32 (range, 25-38 years). Most patients (75%) had stage IB1 disease. Sixty-six patients (63%) were nullip-
arous. Thirty-five women were actively attempting conception 6 months after surgery, and 23 (66%) 
women were successful in conceiving: there were 20 live births, 3 elective terminations, and 4 spontane-
ous miscarriages. Four patients had 2 pregnancies each; all delivered their second pregnancy between 32 
and 36 weeks. Cerclage erosion through the vaginal wall occurred in 6 cases and was treated by transvag-
inal removal of protruding suture material. One of these patients experienced a second trimester miscar-
riage. In conclusion: the majority of women who attempted to conceive after radical trachelectomy were 
successful, and most of their pregnancies resulted in full-term births.  
Finally, even more intriguing, recent studies have suggested that even more conservative tech-
niques such as cervical conization, with or without pelvic lymphadenectomy, may be applicable in treat-
ment of early-stage cervical cancer including stage IB1 (Maneo et al., 2011). If the surgical community 
accepts the findings of these early reports, minimally invasive techniques including simple conization or 
trachelectomy plus lymphadenectomy may need to either become more challenging, with cases with more 
advanced presurgical staging, or totally lose ground as treatment alternatives. Assisted reproduction 
played an important role in select women. Cerclage likely contributed to a post-trachelectomy uterine 
ability to carry a pregnancy to the third trimester. The second post-trachelectomy pregnancy appears to be 
at higher risk for preterm delivery than the first pregnancy. In term of histopatological outcomes there is 
no evidence. 
11 Comparison between Laparoscopy and Robotic in Radical Hysterec-
tomy 
There is a growing trend to practice less aggressive surgery in order to preserve fertility in young women 
and avoid an excess of treatment in some selected patients and nerve-sparing techniques can help to im-
prove the quality of life. Laparoscopic robotic-assisted radical hysterectomy with nerve sparing technique 
is an attractive surgical approach for early invasive cervical cancer. Robotic technology allows a stereo-
scopic visualization of blood vessels and autonomic nerve supplies (sympathetic and parasympathetic 
branches) to the bladder and rectum making nerve sparing a safe and feasible procedure (Gil-Ibáñez et 
al., 2013). 
Magrina et al. (2008) recently presented the first prospective study comparing the perioperative 
results of patients undergoing radical hysterectomy and lymph node dissection by robotics, laparoscopy 
and laparotomy. Mean operating time for a robotic, laparoscopic and radical hysterectomy per laparoto-
my was 190, 220 and 167 min, respectively; mean blood loss was 133, 208 and 444 mL respectively; 
mean number of removed lymph nodes was 26, 26 and 28, respectively, and mean hospital stay was 1.7, 
2.4 and 3.6 days, respectively. There were no significant differences in intra- or postoperative complica-
tions among the three groups and no conversions in the robotics or laparoscopic groups. At a mean follow 
up of 31 months, none of the patients with cervical cancer experienced a recurrence. The authors con-
cluded that laparoscopy and robotics are preferable to laparotomy for patients requiring radical hysterec-
tomy, with advantages like significantly shorter operating times noted for robotics over laparoscopy. 
Their results are in accordance with other groups, although some reported the feasibility of a more radical 
lymph node dissection with the robotic system when compared to conventional laparoscopy (Boggess, 
2007; Kim et al., 2008). Several case reports suggest that debulking surgery is a further potential applica-
tion for robotics surgery in gynaecological oncology (Chavin, 2008; van Dam et al., 2007). 
In a recent paper, Cho and Nezhat (2009) compared robotic and laparoscopy in gynecological on-
cology. The objectives of their article were to review the published scientific literature about robotics and 
its application to gynecologic oncology to date and to summarize findings of this advanced computer en-
hanced laparoscopic technique. Relevant sources were identified by a search of PUBMED from January 
1950 to January 2009 using the key words Robot or Robotics and Cervical cancer, Endometrial cancer, 
Gynecologic oncology, and Ovarian cancer. Appropriate case reports, case series, retrospective studies, 
prospective trials, and review articles were selected. A total of 38 articles were identified on the subject, 
and 27 were included in the study. The data for gynecologic cancer show comparable results between ro-
botic and laparoscopic surgery for estimated blood loss, operative time, length of hospital stay, and com-
plications. Overall, there were more wound complications with the laparotomy approach compared with 
laparoscopy and robotic-assisted laparoscopy. There were more lymphocysts, lymphoceles, and 
lymphedema in the robotic-assisted laparoscopic group compared with the laparoscopy and laparotomy 
groups in patients with cervical cancer. Overall, 126 robotic-assisted laparoscopies, 68 laparoscopies, and 
136 laparotomies were performed in the cohort studies of cervical cancer, each with varying intraopera-
tive and postoperative issues. In the robotic-assisted laparoscopy group, there were 24 complications, 
with lymphocysts or lymphoceles, infections, and vaginal cuff complications most commonly reported. In 
the traditional laparoscopy group, there were 16 complications, with lymphocysts or lymphoceles and in-
fections most commonly reported. In the laparotomy group, there were 24 complications, with adverse 
wound and gastrointestinal sequelae most commonly reported. 
Computer-enhanced technology may enable more surgeons to convert laparotomies to laparoscop-
ic surgery with its associated benefits. It seems that in the hands of experienced laparoscopic surgeons, 
final outcomes are the same with or without use of the robot (Cho & Nezhat, 2009).  
Lambaudie et al. (2010) compared the feasibility and efficacy of 22 robot-assisted laparoscopies 
with 20 traditional laparotomy and 16 conventional laparoscopy in a series of patients with locally ad-
vanced cervical cancer managed in two institutions. In the results, there was no significant difference be-
tween the three groups in terms of body mass index, FIGO stage, or tumor histology. Complication rate 
was similar in the three groups of patients, although there was a trend towards more lymphatic complica-
tions in the robot-assisted subgroup managed medically. There was no significant difference in the recur-
rence rate between the robot-assisted laparoscopy, conventional laparoscopy and laparotomy groups 
(27.3%, 29.4% and 30%, respectively). Authors concluded that robot-assisted laparoscopy is feasible af-
ter concurrent chemoradiation and brachytherapy in cases of locally advanced cervical cancer, reduces 
hospital stay, and seems to result in less severe complications than conventional laparotomy without 
modifying the oncological outcome. 
12    Complications of Endoscopy in Cervical Cancer 
Robotics, like any novel technology, has its advantages, disadvantages and reported complications. In the 
modern era of minimally invasive techniques, current developments in surgical robotics represent only 
the initial attempts to simplify complex laparoscopic procedures, providing precision in dexterity and per-
fection of repetitive tasks such as suturing. The current evidence shows that minimally invasive surgery is 
associated with less morbidity compared with open surgery and can be considered as an alternate option 
for surgical management of cervical cancer without compromising the oncologic outcome. There are sev-
eral studies in literature, which compared laparoscopic or robotic surgeries with open method. In a major-
ity of the studies, the operating time for laparoscopy was higher compared with the open method (Li et 
al., 2007; Malzoni et al., 2009). 
In comparative studies, laparoscopic and robotic methods were associated with shorter hospital 
stay when compared to the open method. Mean blood loss and transfusion rates were more for the open 
method. In a comparative study between laparoscopic and robotic radical hysterectomy, Nezhat et al. 
(2008) showed that there is no difference between operating time, hospital stay, mean pelvic lymph node 
yield or intraoperative or postoperative complications between the robotic and laparoscopic method. The 
complication rates of robotic radical hysterectomy are lower compared to our historical cohort of radical 
hysterectomy by standard laparotomy. 
Many authors and surgeons affirm that some complications may be associated with robotic or lap-
aroscopic surgery per se. The frequent reported complications are on vaginal cuff (dehiscence, lymphatic 
leaking, infection, hematoma, vault prolapse, short vagina), on the lymphatic system (proximal 
lymphedema, mild distal lymphedema, severe distal lymphedema, lymphocyst), on the neural peripheral 
system (genitofemoral nerve injury, partial obturator nerve palsy), on the abdominal wall (port site her-
nia, port site muscle rupture, hematoma, port site metastases) and the vascular system (postop hemoglo-
bin and/or transfusion, ovarian vein thrombosis and pulmonary embolism). 
Symptomatic postoperative lymphocysts (SPOLs) and lower-limb lymphedema (LLL) are proba-
bly underestimated complications of lymphadenectomy for gynecologic malignancies. Adjuvant radio-
therapy was significantly associated with the development of lymphedema in women who had undergone 
radical surgery with lymphadenectomy for FIGO stage I to stage IIA cervical cancer (odds ratio, 3.47; 
95% confidence interval, 2.086-5.788; P = 0.000) (Kim et al., 2012). Moreover, there are also risks of in-
fection by pneumonia, with pyelonephritis and/or fever of unknown origin, a risk of ureter stenosis and of 
uncorrected positioning, with arm/shoulder/leg pain. 
In the Piver study, there were 2 deaths (one from pneumonia and one from pelvic abscess), 2 pulmonary 
emboli, one ureterovaginal fistula and one ureteral stricture and a total of 15 complications in 55 patients 
who underwent type III open radical hysterectomy (27%). Moreover, Piver et al. (1974) showed a 5-year 
disease-free interval of 87.5–100% in women with cervical cancers less than 3 cm treated by type III rad-
ical hysterectomy. 
About the incidence of port site hernia and/or dehiscence after laparoscopic surgery and robotic 
assisted surgery in oncology, literature has recent evidences. The incidence of port site hernia and/or de-
hiscence using bladeless trocars is 0-1.2%. Robotic surgery uses additional port sites and increases ma-
nipulation of instruments, raising the concern for more complications. Authors reviewed Robotically-
assisted (RA) 842 procedures performed for suspected gynecologic malignancy between 1/2006 and 
12/2011. Bladeless 12mm and 8mm robotic trocars were used. Fascial closure was not routinely per-
formed except after specimen removal through the port site. The decision to close the fascia remained at 
the discretion of the surgeon. RA-total laparoscopic hysterectomy (TLH)±unilateral or bilateral salpingo-
oophorectomy (BSO)±lymphadenectomy (LND) accounted for 91.6% of procedures. Final pathology 
confirmed malignancy in 58.6% of cases, primarily endometrial cancer. In 35 cases, the specimen was 
removed through the port site; fascia was closed in 54.3% of them and no port site hernias or dehiscences 
occurred. In the study conclusion, authors affirmed that port site hernias and dehiscences are rare in RA 
gynecologic oncology procedures. When bladeless dilating trocars are used, routine closure of even up to 
a 12mm port site is unnecessary, even in cases requiring removal of the specimen through the trocar sites 
(Boone et al., 2013). 
13   Literature Drawbacks Concerning Robotic Surgery in Gynaecologi-
cal Oncology 
In recent years, robotic surgery or robot assisted surgery has been developed to support a range of surgi-
cal procedures. Robotic surgery in cervical and endometrial cancer is one of the fastest growing areas. 
Robotic surgical systems have been used to perform surgery for endometrial, cervical cancer and ovarian 
cancer. There is mounting evidence which demonstrates the feasibility and safety of robotic surgery for 
gynaecological oncology. 
Cochrane Gynaecological Cancer Group evaluated in 2012 all randomised controlled trials 
(RCTs) comparing robotic assisted surgery for gynaecological cancer to laparoscopic or open surgical 
procedures as well as RCTs comparing different types of robotic assistants. To review authors inde-
pendently screened studies for inclusion and no RCTs were identified (Lu et al., 2012). The robotic ap-
proach was explored in a study by Lambaudie et al (2010); it seemed safe in cases where surgery follows 
neoadjuvant chemotherapy for locoregional extensive tumours. In a study comparing robot-assisted lapa-
roscopy, conventional laparoscopy and laparotomy groups, there was no difference in the recurrence rate 
(27.3 %, 29.4 % and 30 %, respectively). Although already known to be commoner after laparoscopic 
hysterectomy than after laparotomy (Chan et al., 2012), a particularly striking finding is a relative high 
number, up to 20 %, of patients with vaginal dehiscence after robot-assisted laparoscopic surgery 
(Persson et al., 2009). This may be explained by the initial use of extensive cautery or tight suturing, 
causing necrosis. Although some authors reported a significant decrease in vaginal cuff dehiscence when 
closing the vagina vaginally instead of laparoscopically (Uccella et al., 2011), others did not find a differ-
ence between the methods of closure (Hwang et al., 2011).  
In recent series, this complication seems to occur less prominently than in the past, maybe due to 
caution with cautery and the use of self-locking sutures. Published experience has suggested that the out-
comes with Robotic Radical Hysterectomy (RRH) are similar to that for patients undergoing a traditional 
radical hysterectomy via an exploratory laparotomy (Cantrell et al., 2010; Estape et al., 2009; Maggioni 
et al., 2009). These primarily single institution series have compared primarily surgical outcomes of pa-
tients undergoing RRH with Laparoscopic RH and/or Abdominal RH. Secondary to the relatively recent 
introduction of roboticassisted radical hysterectomies, limited information regarding oncologic outcomes 
specifically in terms of survival is available. Overall, these studies have suggested that robotic surgery is 
generally longer, with less estimated blood loss and similar nodal yield.  
Lowe et al. (2009) reported their multi-institutional experience in a group of 42 patients undergo-
ing Type II or III RRH. Overall 42 patients underwent either a Type II or III RRH with operative out-
comes similar to other series and an overall low complication rate of 4.8%. Many authors affirmed that 
robotic total laparoscopic radical hysterectomy with pelvic and para-aortic lymphadenectomy is feasible 
and may be preferable over laparoscopic or radical abdominal hysterectomy. They reported advantages to 
both minimally invasive approaches, with decreased average estimated blood loss, length of stay, number 
of catheter days, days on pain medication, and a faster return to work in both the robotic and laparoscopic 
groups when compared to laparotomy. 
Even with increased visualization and surgical precision, complications still may occur. A large 
review from Kho et al. (2009) at the Scottsdale Arizona Mayo Clinic of >500 patients undergoing various 
robotic-assisted surgical procedures noted a 4.1% (95% CI 2.3–5.8%) vaginal cuff dehiscence rate. Of 
these 21 patients, 9 (43%) had a pre-operative diagnosis of cancer including 3 with cervical carcinoma.  
This rate is similar to the 7.5% incidence seen in the cervical cancer series from Italy by Maggioni et al. 
(2009), although as they note in their follow-up letter to the editor, following a modification in surgical 
technique, the incidence in their patients has decreased to 1% (Sert, 2010). Although unlikely, based on 
the size of the predicted fascial defect, herniation of small bowel through an 8-mm robotic trocar has been 
reported (Seamon  et al., 2008). 
The published data comparing different surgical approaches to radical hysterectomy, including 
traditional laparoscopy or laparotomy show that the robotic approach produces more favorable periopera-
tive outcomes, such as less blood loss, abbreviated hospitalizations, and equivalent or lower rates of in-
traoperative and postoperative complications. While these series are relatively small and non-randomized, 
they consistently demonstrate safety and efficacy with respect to complications, blood loss, operative 
time and patient convalescence comparing robotic assisted surgery with laparoscopy (Estape et al., 2009; 
Magrina et al., 2008; Nezhat, 2008; Symmonds, 1975). Despite that these findings are consistently repro-
ducible in larger and multi-institutional studies, there are no prospective data to resolve these unequivocal 
comparisons in cervical cancer patients. We hope that the prospective randomized controlled trial that is 
currently ongoing will provide further insight. Although robotic-assisted technology is supposedly an en-
hancement of conventional laparoscopy, several studies have reported conversion of the robotic approach 
to laparotomy, not laparoscopy. There were 6 conversions from robotic-assisted laparoscopy to laparoto-
my in 2 studies (Boggess et al., 2008). 
14    Pro and Contra of Robotic Assisted Surgery 
In 2005, the first feasibility studies in both Europe and the United States were published, since robotic-
assisted procedures provide several advantages. Binocular vision and 3-dimensional views permit im-
proved depth perception, which may facilitate advanced laparoscopic procedures, such as intracorporeal 
suturing. The console is located away from the patient and permits the surgeon to operate in a comforta-
ble, seated position, thus making operator positioning more ergonomic. 
Tremor filtration is another benefit of robotic-assisted surgery, as the video laparoscope is no 
longer in a human hand, which may tire or move, but rather is fixed in position by the robotic arm. This 
feature permits finer surgical movements with more precise dissections. The articulating instrument tips 
that are utilized in traditional laparoscopy are taken to a new level with not only rotational capabilities but 
an independent 90-degree articulation of the tip. These features make robotic surgery more intuitive, with 
a shorter learning curve. Additional robotic arms have been introduced to further minimize the need for 
surgical assistants in institutions that may have limited staff. 
Robotic-assisted procedures are not, however, without their limitations. The equipment is still 
very large, bulky, and expensive. The staff must be trained specifically on draping and docking the appa-
ratus to maintain efficient operative times. Functional limitations include lack of haptic feedback, limited 
vaginal access, limited instrumentation, and larger port incisions requiring fascial closure. In terms of 
haptic feedback, visual cues become imperative to ensure that tissue manipulation is not performed with 
undue force. Intracorporeal knots must be tied carefully such that the suture is not avulsed by the strength 
imposed by the robotic arm. Limited vaginal access can be problematic in gynecologic surgery as fre-
quent uterine or vaginal manipulation is necessary, particularly in extirpative procedures. Once the robot 
has ascended into place, access to the vagina becomes markedly limited. Robotic accessory trocars are 8 
mm in size with a 12 mm laparoscope. These incision sizes are larger than the 5 mm accessories that are 
frequently used in traditional laparoscopy and also require fascial closure, with higher risks of herniation.  
The robot is also limited in its instrumentation. Exchanging instruments becomes more cumber-
some and requires a surgical assistant to change the instruments. Additionally, the current robotic instru-
ments do not include endoscopic staplers or vessel sealing devices. Moreover, the trocars required for ro-
botic procedures are larger than those used for traditional laparoscopy. In radical hysterectomy, the dis-
section of the uterine arteries, ureteral tunneling, and vaginal cuff closure are among the most useful indi-
cations for robotic-assisted procedures. The greater range of motion afforded by the robotic instruments 
permits easier maneuverability for these dissections. 
These multiple optional of robotic-assisted surgery had been evaluated by literature. A recent pa-
per on robotics has definitely been shown that robotic surgeries are more costly than regular laparoscopic 
approaches (Shah et al., 2011). Nevertheless, one study found an additional $3000 in operative case per 
robot-assisted vs laparoscopic hysterectomy (Jonsdottir et al., 2011). This cost differential may change 
with a decrease as other robotic systems come on line in the future. Moreover, another blinded, prospec-
tive randomized controlled trial comparing operative time and intra- and postoperative complications be-
tween total laparoscopic hysterectomy and robotic-assisted total laparoscopic hysterectomy, concluded 
that, although laparoscopic and robotic-assisted hysterectomies are safe approaches to hysterectomy, ro-
botic-assisted hysterectomy requires a significantly longer operative time. The lengthier times in the robot 
group are likely due to operating room set up, docking time, troubleshooting of technical aspects that may 
be faulty with the robot (e.g., collision of arms, malfunctioning instrumentation), and less efficient elec-
trosurgical vessel-sealing instrumentation for robot-assisted surgery during the time that this trial was un-
dertaken (Paraiso et al., 2013). 
A recent investigation show that robotic-assisted laparoscopy is safe, effective, and successful in 
obese and morbidly obese patients who undergo hysterectomy for malignancy which further decreases 
the incidence of laparotomy in the future (Leitao et al., 2012) and an American study on 1000 cases on 
robotic surgery (RS) in oncology from May 2006 through December 2009, analyzed patient characteris-
tics and outcomes on a total of 377 women undergoing RS for endometrial cancer staging (ECS), com-
pared with the historical data of 131 undergoing open ECS. Authors concluded that RS is associated with 
favorable morbidity and conversion rates in an unselected cohort. Compared to laparotomy, robotic ECS 
results in improved outcomes (Paley et al., 2011). Thus, after data revision, robot-assisted hysterectomy 
does not confer any perioperative patient benefits over laparoscopic hysterectomy in the hands of experi-
enced conventional laparoscopic surgeons, except in gynecological oncology, where robotics have ad-
vantages (Rodriguez, 2013).  
15    Conclusions 
The robotic-assisted surgery has emerged as an invaluable minimally invasive approach to comprehen-
sive surgical staging and the treatment of cervical cancer. There is good evidence that robotic surgery fa-
cilitates laparoscopic surgery, with equivalent if not better operative time and comparable surgical out-
comes, shorter hospital stay, and fewer major complications than with surgeries using the laparotomy ap-
proach. And the role of robotic-assisted surgery is still expanding (Krill & Bristow, 2013). In addition to 
radical hysterectomy, gynecologic oncologists are applying robotic technology to ovarian transposition, 
lymphadenectomy, and even tumor debulking. Some future directions that will further the scope of robot-
ic-assisted surgery include incorporation of the robotic system in the operating room facility to permit 
better accessibility to the patient during the procedure as well as expansion in instrumentation. Total lapa-
roscopic radical hysterectomy is a feasible and safe procedure that is associated with fewer intraoperative 
and postoperative complications than abdominal radical hysterectomy. Longer follow-up is needed, but 
early data are supportive of at least equivalent oncologic outcomes compared with other surgical modali-
ties. The role of robotic-assisted surgery is continuing to expand and new promising approaches with 
added benefits are emerging, such as the one of the ALF-X system. Surgeons await results from addition-
al series of radical hysterectomy performed by robo-endoscopic assisted surgery and from International 
prospective randomized trial evaluating outcomes in patients randomly assigned to either open or laparo-
scopic/robotic radical hysterectomy. 
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